落地中山医院！国内首个实体化心脏瓣膜疾病中心

Core Viewpoint - The establishment of the Fudan University Zhongshan Hospital Heart Valve Disease Treatment Center marks a significant advancement in the diagnosis and treatment of heart valve diseases in China, emphasizing a multidisciplinary approach to patient care [1][7][10]. Group 1: Heart Valve Disease Overview - Heart valve disease is a common yet complex cardiovascular condition affecting the heart's valve structures, leading to serious complications such as heart failure and arrhythmias [3][5]. - The prevalence of heart valve disease in China is approximately 3.8%, equating to around 25 million patients, with a notable increase in risk for individuals over 60 years old [5][10]. Group 2: Treatment Innovations - Advances in medical technology have shifted treatment strategies from traditional open surgery to minimally invasive procedures and transcatheter interventions, allowing for earlier intervention in high-risk patients [5][10]. - The Zhongshan Hospital Heart Valve Disease Center integrates various medical disciplines to create a comprehensive treatment model, enhancing the efficiency of care for critically ill patients [7][9]. Group 3: Center's Achievements and Future Plans - Since its establishment, the center has performed nearly 1,000 interventional valve surgeries and over 1,100 minimally invasive surgeries, positioning itself among the international leaders in this field [10]. - The center aims to continue fostering the integration of clinical practice, research, and translational medicine to contribute to the "Healthy China" strategy and improve the management of major cardiovascular diseases [10].